Shorter vs. longer blood thinners after bridge stent for neck artery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two different lengths of blood-thinner therapy after getting a Bridge stent for a narrowed artery in the back of the neck. It aims to find the best way to prevent future strokes with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a narrowed artery in the back of your neck (≥70% blockage) that has caused a stroke or mini-stroke despite being on blood thinners.
- You are suitable for a Bridge stent implant.
- You are not disabled (mRS score less than 3).
- You do not have other serious brain conditions (like aneurysm, tumor, or active infection).
- You are not at high risk of bleeding (e.g., no active ulcers or recent brain bleed).
- You are not allergic to the medications or materials used in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
This trial tests if placing a drug-coated stent in a narrowed artery in the neck, followed by a shorter course of two blood thinners, can better prevent another stroke in people with symptomatic vertebral artery stenosis.
This study compares two combinations of blood thinners to see which works better for preventing clots after a stent procedure to treat an unruptured brain aneurysm. It is for people who have a specific gene test result that shows they process medicines normally.
This trial compares a short course versus a longer course of antiplatelet medicine (blood thinners) after a TAVI procedure for aortic stenosis. It aims to see which approach is safer and more effective.
This study compares ticagrelor taken at a lower dose versus regular aspirin to help prevent future heart attacks in people who recently had a stent placed after acute coronary syndrome. You may qualify if you’re considered “high risk” for new blockages or clots and can take dual anti-platelet therapy for 12 months.
This trial compares two common blood-thinning medications (prasugrel vs ticagrelor) and two treatment durations (short 1–3 months vs standard 12 months) after a heart attack treated with stents. It aims to find the most effective and safest anti-clotting strategy for patients.
Hear when a new Vertebral Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.